企業プロフィール
ACADIA Pharmaceuticals Inc. 株価・ニュース・カタリスト
- ティッカー:
- ACAD
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
29.01 USD (+2.73%)
終値
最終更新: 2026年8月17日
3.58B USD
時価総額
株価変動の要因
As of Aug 17, 2026, ACAD closed up 2.73% at $29.01. No new same-company headline was identified in the current news window.
企業概要
事業概要
Acadia Pharmaceuticals is a biopharmaceutical company focused on neuroscience and rare disease, with commercial products in areas such as psychosis and movement disorders. Its business combines marketed therapies with a pipeline aimed at CNS and specialty indications.
所在地とセクター分類
Acadia is headquartered in the United States and listed on NASDAQ. It sits in specialty neuroscience biopharma.
ビジネスモデルの特徴
The company depends on product sales, launch execution, and pipeline expansion across CNS and rare disease. Investors watch revenue growth, label breadth, and development milestones.
バイオ業界での位置付け
Acadia occupies a strong specialty-neuroscience niche within biotech. It has more commercial footing than a typical development-stage company, but still reacts to pipeline and launch developments.
今後のカタリスト
- Acadia’s catalysts are DAYBUE execution, near-term CNS franchise updates, and any label / commercial step that broadens the company’s growth base. The company’s value depends on turning its CNS assets into a more durable franchise.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。